The DOI matches its Crossref record.
Protecting Research Subjects — What Must Be Done
Abstract
As we race toward the as yet unimagined scientific and medical triumphs of the 21st century, no one is more hopeful about the journey than I am. Nevertheless, moving ahead with cutting-edge research must not mean leaving behind well-established international standards for protecting human subjects in clinical trials. None of these principles is more important than the protection of research subjects by informed consent based on full disclosure of potential risks and benefits.I did not expect, or want, to complete my tenure as secretary of health and human services by raising questions about the safety of patients in clinical . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816
“The nation’s medical leadership warned that public trust in research might falter if action were not taken.(13,14) However, attempts todevelopnewconflictof interest policies have encountered substantial controversy.”
Corbie-Smith, G., Thomas, S. B., & St. George, D. M. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.21.2458 · Cited by 1,072
Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency
Wilson, J. M. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.12.016 · Cited by 299
Obstacles facing translational research in academic medical centers
POBER, J. S., NEUHAUSER, C. S., & POBER, J. M. (2001) · The FASEB Journal · doi:10.1096/fj.01-0540lsf · Cited by 132
(2004) · PubMed · Cited by 56
Metadata
- Authors
- Shalala, D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2000-09-14
- Volume
- 343
- Issue
- 11
- Pages
- 808-810
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2050029323
- Cited by
- 190
- References
- 0
- FWCI
- 27.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protecting Research Subjects — What Must Be Done. https://app.cochat.ai/papers/10.1056/nejm200009143431112
- The paper
- Shalala, D. (2000). Protecting Research Subjects — What Must Be Done. New England Journal of Medicine. https://doi.org/10.1056/nejm200009143431112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.